Antiplatelets, anticoagulants, and colonoscopic polypectomy - 22/01/20
Abstract |
The management of antiplatelet and anticoagulant (ie, antithrombotic) agents is challenging in the periendoscopic setting. In this state-of-the-art update, we review current best practice recommendations focusing on the risk of immediate and delayed postpolypectomy bleeding in the context of drug discontinuation (ie, temporary interruption) and drug continuation. The data regarding polypectomy technique (cold snare vs conventional thermal-based) and prophylactic placement of hemostatic clips are evaluated to assess whether these endoscopic techniques are beneficial in reducing postpolypectomy bleeding. Finally, clinical takeaways are provided to facilitate safer polypectomy among patients on antiplatelet and anticoagulant agents.
Le texte complet de cet article est disponible en PDF.Abbreviations : ASA, BRIDGE, CSP, CUP, DOAC, ORBIT-AF, PPB, RE-LY
Plan
| DISCLOSURE: The following author received research support for this study from the Agency for Healthcare Research and Quality (grant R01HS025402): N. S. Abraham. The content is solely the responsibility of the author and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication were solely the responsibility of the author listed. The author disclosed no other financial relationships relevant to this publication. |
Vol 91 - N° 2
P. 257-265 - février 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
